Event Date: Apr 25, 2017
In addition to its physical symptoms, MS may bring about changes in mood and cognition. At first, it may be difficult to adjust to the diagnosis of a disorder that is unpredictable, and carries a risk of progressing over time to some level of physical disability. In the face of MS, people may tend to focus primarily on their physical health and neglect their emotional health—which is an essential component of overall health and wellness.
Dr. Anthony Feinstein will discuss treatment options, research, and issues relating to mood and cognitive changes.
This is the 5th of an 8-part learning series brought to you blearning series brought to you by MS Canada. Click here
to see future session information and / or access previous, archived sessions.
This session is hosted by the Multiple Sclerosis Society of Canada
who gratefully acknowledges the support of Biogen
who provided an education grant which makes possible the MS Webinar Series.
Dr. Anthony Feinstein, M.B.B.Ch., M.Phil., PhD, FRCPC
Anthony Feinstein is a Professor of Psychiatry at the University of Toronto and a neuropsychiatrist. His research and clinical work focuses on people with multiple sclerosis, traumatic brain injury and Conversion Disorder.
Over a three decade period, Feinstein's work has focused on determining brain imaging correlates of depression and pseudobulbar affect in people with MS. He has also developed computerized methods of detecting cognitive dysfunction, with a particular emphasis on the use of distracters. A third strand to his MS work relates to defining the cognitive and functional neuroimaging changes associated with the use of cannabis (marijuana) in people with MS. His research has been funded by the Multiple Sclerosis Society of Canada, the Canadian Institute of Health Research and the Progressive MS Alliance.